A panel of dermatologists develops core principles, consensus statements and a treatment algorithm for the management of atopic dermatitis with topical products.
Do we have to choose between the duty to relieve patients' severe pain as best we can, and the duty to protect them from the potential harm associated with first-time opioid use?